The SIL1 gene plays a crucial role in the development and maintenance of clear lenses in the eyes and proper muscle function. Mutations in the SIL1 gene are closely associated with a rare genetic disorder known as Marinesco-Sjögren Syndrome (MSS), which is characterized by congenital cataracts, progressive muscle weakness, cerebellar ataxia, and developmental delays. Identifying mutations in the SIL1 gene is crucial for the diagnosis and understanding of the syndrome, allowing for better management and care of affected individuals.
DNA Labs UAE offers a genetic test specifically designed to detect mutations in the SIL1 gene, providing a valuable tool for diagnosing Marinesco-Sjögren Syndrome and associated congenital cataracts. This test is particularly important for individuals showing symptoms of MSS or those with a family history of the syndrome. Early detection through genetic testing can facilitate timely intervention and support, potentially improving the quality of life for those affected.
The cost of the SIL1 gene cataract congenital associated with Marinesco-Sjögren Syndrome genetic test at DNA Labs UAE is 4400 AED. The test involves a simple sample collection process, after which the sample is analyzed for specific genetic mutations in the SIL1 gene. Results from the test can provide crucial information for families and healthcare providers, guiding further medical and supportive care decisions for individuals with MSS.
The "LIM2 Gene Cataract Cortical Pulverulent Late-Onset Genetic Test" is a specialized diagnostic examination designed to identify mutations in the LIM2 gene, which are associated with the development of late-onset cortical pulverulent cataracts. Cataracts are characterized by the clouding of the lens in the eye, leading to decreased vision, and the LIM2 gene plays a crucial role in maintaining lens transparency. Mutations in this gene can disrupt lens fiber cell membrane integrity, leading to the formation of cataracts.
This genetic test is particularly valuable for individuals who have a family history of cataracts or have been identified as having symptoms suggestive of this specific type of cataract. Early identification of mutations can aid in the management and treatment planning for affected individuals, potentially leading to better outcomes.
The test is conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the test is set at 4400 AED. It involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of mutations in the LIM2 gene. Results from this test can provide crucial information for patients and their families regarding the risk of developing late-onset cortical pulverulent cataracts and can guide decisions about monitoring and intervention strategies.
The HSF4 Gene Cataract Lamellar Genetic Test is a specialized diagnostic procedure designed to identify mutations in the HSF4 gene, which are known to cause lamellar cataracts. Lamellar cataracts are a specific type of cataract characterized by a layered, opacification of the lens, which can lead to impaired vision. This genetic testing is crucial for early detection and management of the condition, potentially preventing severe vision loss.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, this test offers a comprehensive analysis of the HSF4 gene to determine an individual's risk of developing lamellar cataracts. The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the lab for any genetic abnormalities associated with the condition.
The cost of the HSF4 Gene Cataract Lamellar Genetic Test is 4400 AED. This investment covers the full process of genetic screening, from sample collection to detailed reporting of results. Given the specialized nature of this test and its potential to significantly impact the management and treatment of lamellar cataracts, it represents a valuable tool for individuals with a family history of the condition or those experiencing symptoms suggestive of cataracts.
The "CRYAB Gene Cataract Posterior Polar Type 2 Genetic Test" is a specialized diagnostic tool used to identify mutations in the CRYAB gene, which are associated with the development of Cataract Posterior Polar Type 2, a specific type of cataract characterized by a distinctive opacity at the back of the lens of the eye. This condition can lead to a decrease in visual clarity and, if left undiagnosed, can progress to more severe vision impairment or blindness. The test is particularly valuable for individuals who have a family history of this condition or exhibit symptoms suggestive of posterior polar cataracts, as early detection can facilitate timely management and treatment strategies.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed to detect any abnormalities or mutations in the CRYAB gene. These mutations are known to disrupt the normal function of alpha-crystallin B, a protein crucial for maintaining the transparency and refractive index of the lens, thereby leading to the development of cataracts.
The cost of the "CRYAB Gene Cataract Posterior Polar Type 2 Genetic Test" at DNA Labs UAE is set at 4400 AED. While the price may seem significant, the value of the test lies in its ability to provide crucial genetic information that can guide clinical decisions, inform treatment options, and potentially prevent the progression of the disease. For families affected by this condition, the test also offers the possibility of genetic counseling and understanding the risk of transmission to future generations.
The "MAF Gene Cataract Pulverulent or Cerulean with or without Microcornea Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the MAF gene, which are known to cause specific types of cataracts. These cataracts can appear as pulverulent (dusty or powdery) or cerulean (blue-dot) and may occur with or without microcornea, a condition where the cornea is abnormally small. The test is critical for individuals who exhibit symptoms of these eye conditions or have a family history of them, as early detection can aid in managing the disease and planning for potential treatments. The cost of the test is 4400 AED, reflecting the specialized nature of the genetic analysis and the sophisticated technology employed to ensure accurate results. Conducted in the state-of-the-art facilities of DNA Labs UAE, this genetic test represents a significant step forward in personalized medicine and offers hope for affected individuals and their families.
The NHS Gene Cataract X-Linked Genetic Test, available at DNA Labs UAE for a cost of 4400 AED, is a specialized diagnostic tool designed to identify mutations in the NHS gene, which are known to cause X-linked congenital cataracts. This type of cataract is inherited in an X-linked recessive pattern, predominantly affecting males, and is characterized by the clouding of the lens of the eye that is present from birth or develops shortly after. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any genetic abnormalities associated with this condition. Identifying these mutations can provide crucial information for families regarding the inheritance pattern, potential for recurrence in future generations, and options for genetic counseling. It is an invaluable resource for affected individuals and their families, offering insights into the genetic underpinnings of X-linked congenital cataracts and guiding decisions regarding management and treatment.
The GJA8 Gene Cataract-Microcornea Syndrome Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the GJA8 gene, which are linked to the development of Cataract-Microcornea Syndrome. This genetic condition is characterized by the presence of cataracts along with microcornea, a condition where the cornea's diameter is less than 10 mm in both eyes, potentially leading to visual impairment.
The test is conducted through a detailed analysis of the patient's DNA to identify any genetic alterations in the GJA8 gene, which plays a crucial role in the development and maintenance of eye lens transparency and corneal size. Identifying mutations in this gene can help in confirming the diagnosis, understanding the risk of transmitting it to offspring, and potentially guiding treatment and management decisions for affected individuals.
At DNA Labs UAE, the cost of the GJA8 Gene Cataract-Microcornea Syndrome Genetic Test is set at 4400 AED. The test provides a crucial resource for families and individuals at risk of this genetic syndrome, offering insights that can lead to early intervention and personalized care plans to manage the condition effectively.
The "IARS2 Gene Cataracts Growth Hormone Deficiency Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the IARS2 gene. Mutations in this gene are associated with a rare, inherited condition that can lead to the development of early-onset cataracts, growth hormone deficiency, and potentially other health issues. This test is crucial for individuals who exhibit symptoms related to these conditions or have a family history of similar genetic disorders. By analyzing the IARS2 gene, healthcare providers can confirm a diagnosis, allowing for early intervention and management of the condition. The test is priced at 4400 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high-quality, reliable results for patients and their families.
The ACO2 gene cerebellar-retinal degeneration infantile genetic test is a specialized diagnostic procedure designed to identify mutations in the ACO2 gene, which are linked to a rare, inherited neurodegenerative disorder. This condition is characterized by early-onset degeneration of the cerebellum and retina, leading to symptoms such as poor muscle coordination, visual impairment, and intellectual disability. Early detection through this genetic test can facilitate timely intervention and management strategies to improve the quality of life for affected individuals.
The test is conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the ACO2 gene test is set at 4400 AED, reflecting the comprehensive analysis and expertise required to accurately identify mutations in this specific gene. By opting for this test, patients and their families can gain valuable insights into their genetic makeup, paving the way for personalized treatment plans and preventive measures for associated conditions.
The PRPH2 Gene Choroidal Dystrophy Central Areolar Type 2 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the PRPH2 gene, which are linked to the development of Central Areolar Choroidal Dystrophy Type 2 (CACD2). This condition is a rare, inherited eye disorder that affects the central area of the retina, leading to progressive vision loss. The test is crucial for early detection and management of the disease, offering insights into potential treatment paths and helping in family planning decisions. Conducted at the state-of-the-art facilities of DNA Labs UAE, the test cost is set at 3200 AED. This genetic testing is a significant step towards personalized medicine, providing patients and their families with crucial information about their genetic health and predisposition to this specific form of choroidal dystrophy.
